Retreatment with sonidegib in a patient with multiple basal cell carcinomas and multiple comorbidities: a complex real-life scenario
Ital J Dermatol Venerol
.
2023 Apr;158(2):150-152.
doi: 10.23736/S2784-8671.23.07281-X.
Epub 2023 Feb 17.
Authors
Francesca Comito
1
2
,
Ambrogio Gagliano
3
,
Francesca Sperandi
4
,
Emi Dika
5
,
Francesco Savoia
6
,
Barbara Melotti
4
Affiliations
1
Unit of Medical Oncology, University Hospital of Bologna, Bologna, Italy - francesca.comito2@unibo.it.
2
Department of Experimental, Diagnostic and Speciality Medicine, University of Bologna, Bologna, Italy - francesca.comito2@unibo.it.
3
Department of Experimental, Diagnostic and Speciality Medicine, University of Bologna, Bologna, Italy.
4
Unit of Medical Oncology, University Hospital of Bologna, Bologna, Italy.
5
Unit of Dermatology, University Hospital of Bologna, Bologna, Italy.
6
Unit of Skin Cancer, Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" - IRST IRCCS, Meldola, Forlì-Cesena, Italy.
PMID:
36799006
DOI:
10.23736/S2784-8671.23.07281-X
No abstract available
MeSH terms
Carcinoma, Basal Cell* / drug therapy
Carcinoma, Basal Cell* / epidemiology
Humans
Retreatment
Skin Neoplasms* / drug therapy
Substances
sonidegib
Supplementary concepts
Basal cell carcinoma, multiple